May 26, 2020 – News
Visit the Specialized Histopathology Core webpage for more information
Latest News
-
-
May 18, 2020 – Funding
NCI would like to increase the number of P01 grants in its portfolio. The NCI Office of Cancer Centers is offering supplemental funding to the P30 Cancer Center Support Grant (CCSG) for the purpose of stimulating the...
-
May 18, 2020 – Funding
The DF/HCC Breast Cancer Program has released RFA's for its Breast SPORE Career Enhancement and Developmental Research Project Awards, with applications due on June 12, 2020. Read more about these awards below for more...
-
May 04, 2020 – Funding
An additional Childhood Cancer Data Initiative (CCDI) P30 supplement announcement has been released. DF/HCC has the opportunity to nominate one application for this supplement, and as such requires an internal vetting...
-
April 27, 2020 – ODQ
REGIST-OP-1 has been updated effective April 27, 2020. Tracked changes are posted on the Policy Updates page.
-
April 27, 2020 – COVID-19
The policy exceptions announced on March 23, 2020 have been extended until at least June 1, 2020. An updated note to file has been posted.
-
April 24, 2020 – Office for Human Research Studies
The previously broadcast DF/HCC training on sIRB reviews and guidance can now be viewed online...
-
April 22, 2020 – Funding
Due on June 15, 2020 with informational webinar on 4/28 at 4pm
-
April 21, 2020 – COVID-19
NCI plans to launch a national, longitudinal, natural history study of COVID-19 in people with cancer in mid May 2020. The study, named NCI COVID-19 in Cancer Patients Study (N-CCaPS), will be open to adults who are...
-
April 20, 2020 – PRMS
A PowerPoint training will be presented for the first half, followed by the opportunity for attendees to submit questions to the panelists in a live Q&A.
We’re happy to announce the DF/HCC’s new Center for Cancer Equity and Engagement. Learn how the CCEE is working to bring DF/HCC research and communities together to eliminate cancer disparities in Massachusetts.
Event Highlights
eNews Latest Issue
Fall 2019
Get eNews in your inbox
The Bridge Project
This is a collaboration between Dana-Farber/Harvard Cancer Center and the David H. Koch Institute for Integrative Cancer Research, designed to bring bioengineering, advanced cancer science, and clinical oncology together to solve today’s most challenging problems in cancer research and care.